Charles River Laboratories International, Inc. (CRL) vs Labcorp Holdings Inc. (LH)
- Charles River Laboratories International, Inc. CRL 299.77 −2.11%
- Labcorp Holdings Inc. LH 318.66 −1.97%
Charles River Laboratories International, Inc. and Labcorp Holdings Inc. are both Diagnostics & Research companies. Labcorp Holdings Inc. is the larger, with a market value of $26.4B against $14.6B — 1.8× the size. Charles River Laboratories International, Inc. has negative trailing earnings, so its P/E is not meaningful; Labcorp Holdings Inc. trades at 26.2×. Labcorp Holdings Inc. grew revenue faster over the last twelve months: 6.41% against −0.74%. Labcorp Holdings Inc. has the higher net margin (6.99% vs −5.96%) and the higher return on invested capital (6.50% vs 1.07%). Across the 21 metrics below, Labcorp Holdings Inc. leads on 17 and Charles River Laboratories International, Inc. on 4.
Valuation
Profitability
| Metric | CRL | LH | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 32.67% | 28.88% | 50.89% |
| Operating margin | 2.25% | 10.43% | (8.57%) |
| Net margin | (5.96%) | 6.99% | (6.37%) |
| Free cash flow margin | 9.27% | 8.16% | 0.00% |
| Return on equity | (7.69%) | 11.74% | (2.92%) |
| Return on assets | (3.16%) | 5.48% | (6.71%) |
| Return on invested capital | 1.07% | 6.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack